Drug intelligence / Profile preview

metformin + ursodeoxycholic acid

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

A combination drug consisting of metformin and ursodeoxycholic acid (UDCA). Metformin is an antidiabetic medication that improves insulin sensitivity and reduces hepatic glucose production, while UDCA is a hydrophilic bile acid with protective effects on the liver. This combination is being studied for treating non-alcoholic steatohepatitis (NASH) and potentially beneficial for patients with type 2 diabetes mellitus (T2DM) due to its complementary effects on insulin resistance, oxidative stress, and liver protection.

02

Targets

AMPK (Adenosine monophosphate–activated protein kinase)PXR (Pregnane X receptor)GR (Glucocorticoid receptor)ABCB11 (Bile salt export pump)FXR (Farnesoid x-activated receptor)ND1 (Mitochondrial electron transport chain complex I)INSR (Insulin receptor)ABCC2 (ATP-binding cassette sub-family C member 2)

Beyond the preview

Go deeper on metformin + ursodeoxycholic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on metformin + ursodeoxycholic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call